Canrenoate Potassium

Known as: Canrenoate, Potassium, Potassium Canrenoate 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Primary aldosteronism (PA) is the most common form of secondary hypertension. The prevalence of PA is raised from 1% to 3% to 10… (More)
Is this relevant?
2004
2004
Aldosterone elevates Na+/K+/2Cl- cotransporter activity in rabbit cardiomyocytes within 15 min, an effect blocked by K-canrenoate… (More)
Is this relevant?
1999
1999
Potassium canrenoate (PC), a competitive aldosterone antagonist used as a diuretic and in the treatment of hypertension, was… (More)
Is this relevant?
1994
1994
Although some clinical studies seem to prove the efficacy of nonantialdosteronic potassium-sparing diuretics in the treatment of… (More)
Is this relevant?
1988
1988
The metabolic fates of potassium canrenoate (PC) and spironolactone (SP) were compared for the rat in vivo and in vitro… (More)
  • table I
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
1985
1985
We have established a sensitive and specific radioreceptor assay for androgen receptor active materials in plasma, using… (More)
Is this relevant?
1976
1976
The efficacy of potassium canrenoate in suppressing frequent ventricular premature depolarizations and ventricular bigeminal and… (More)
Is this relevant?
1976
1976
The pharmacological activity of single doses of the two aldosterone antagonists, potassium canrenoate and spironolactone, was… (More)
Is this relevant?
1976
1976
Effects of spironolactone, canrenone and canrenoate-K on adrenal cytochrome P450 (P450) and corticosteroid biosynthesis were… (More)
Is this relevant?
1974
1974
Plasma concentrations of canrenone and canrenoate were measured in 43 patients treated with spironolactone 50–400 mg/day, and in… (More)
  • figure 1
  • figure 3
  • table 1
  • figure 4
Is this relevant?